NCT02578797 2023-11-09A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc StudyAragon Pharmaceuticals, Inc.Phase 1 Completed45 enrolled
NCT03490032 2020-11-17PROfindAdvanced Accelerator ApplicationsPhase 1/2 Completed30 enrolled 30 charts
NCT03077659 2019-08-20Trial of NanoPac® Focal Therapy in Subjects With Prostate CancerNanOlogy, LLCPhase 2 Completed16 enrolled 12 charts
NCT01316458 2017-06-01Glivec in Prostate Cancer Patients With Rising PSA Following Radical ProstectomyNovartisPhase 2 Completed51 enrolled
NCT01431391 2017-05-30Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate CancerDendreonPhase 2 Completed68 enrolled 11 charts
NCT00753415 2015-03-17A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)Merck Sharp & Dohme LLCPhase 1 Completed37 enrolled 10 charts
NCT00749502 2013-07-25A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)Tesaro, Inc.Phase 1 Completed113 enrolled